Makes Smart People Smarter!
Here's the Latest Developments...
(Last Updated: Sat, May 18, 2024 at 7:49am)
Drug Growth
#Drugs 24019 |
Year to Date Change |
New |
909 (3.93%) |
Updated |
4964 (26%) |
Events |
39633 |
Target Growth
#Targets 2110 |
|
New (Last 12 months) |
110 |
Unique to One Drug Across Oncology |
808 (38%) |
|
|
Changes to the Competitive Landscape
#Competitors 7746 |
New YTD |
Startup |
Public |
Private |
186 |
926 |
1409 |
4829 |
Clinical Trial Development
#Trials 24051 |
Year to Date Change |
New |
Status Change |
Results |
699 |
1599 |
1498 |
Deals & Alliances
#Deals 9507 |
5 Year Breakdown |
M&A |
R&D |
Diagnostics |
Manufacturing |
Marketing |
939 |
3731 |
347 |
871 |
360 |
Filings & Approvals
#Approved Drugs 752 |
Orphan Designations |
Breakthrough Designations |
3484 |
301 |
Know Your Competitive Landscape
With 1stOncology's
award winning intelligence you can generate your own market leading insights reports by continuously monitoring growth of companies, drugs, funding and deals in your area of interest, from discovery to market.
Across all of oncology we add a new drug every 4th hour and a new player in oncology every 12th hour! Apart from closely monitoring more than 6,000 active organizations world-wide, we also follow the scientific literature and an ever-growing number of world-leading meetings in oncology like AACR, ASCO, ASH, ESMO etc., giving our clients a competitive edge. 1stOncology leads the way in capturing commercial grade academic research projects and startups.
It is our robust methodology and technology, non-stop focus in oncology, level of granulation and world-wide advisory network of Key Opinion Leaders which makes us the
tool of choice in understanding your Competitive Landscape!
Power In/Out Licensing
Find out the latest deals and alliances, know the positions taken and where to go from there. Identify who could have a potential interest in your technology or complements your strategic drug development direction.
Our Deals and Alliance breakdown also helps you identify partners in important areas like R&D, clinical development, diagnostic, manufacturing etc.
With our rich list of Business Development and Licensing (BD&L) contacts you can hit the ground running in your out-reach.
Boost Reports & Presentations
Whether you are working on an internal strategy document or preparing your latest conference/corporate/investor presentation we have the latest information and breakdowns to sharpen presentations and continuously be up to date.
Locate KOLs
1stOncology helps you to identify both clinical and scientific key-opinion leaders (KOLs) in your particular field of interest. These are trusted individuals, respected by companies, the scientific/clinical communities and niche audiences and can provide recommendations and opinions prior to important decisions.
Find Investors
Finding the right investors for your business is a crucial step in its growth journey. 1stOncology helps you to identify proven investors already financing your field of interest.
Try for Free
Our 7-day trial requires no credit card and you can pick your start date!
7 Day Free TrialDrug Modality Specific Features
Drug modality areas like ADC, Bi/Multispecfic, CAR/TCR, Oncolytic Virotherapies and more come with their own specific features and granulations. For example, 1stOncology provides great granulation specifically towards bi/multispecific drugs, like TCEs, NKCEs, ADCs, Bi/multi specific, Dual immunomodulator, Conditional drug activation, Unique Targets, Use of CDx etc.
Your Conference Year? Covered!
Executive companion reports and online tools to analyze an ever-growing number of world-leading meetings in oncology like AACR, ASCO, ASH, ESMO etc.
1stOncology is also present at
several leading industry meetings including Immuno-Oncology, Biologics, Target Discovery, Diagnostics and much more.
Proven & Award-winning Solution
1stOncology was the main analysis tool behind a bone metastasis
peer reviewed publication (Frontiers in Immunology (IF 7.3) and the 2023 recipient of the
Top 10 Global Pharma Analytics Provider award.
A Top 10 Global Pharma Analytic Provider
"Our mission is to deliver a superior intelligence service to cancer drug stakeholders and to make 1stOncology the go- to solution for those who are serious about their investment in oncology"
Insights You Can Trust
Since 1999, we have been 100% dedicated and focused on oncology and for 25 years now, we have provided our world-wide client base with the scientific and business insights required for time-saving and accurate analysis of competing drug development and corporate strategies.
The 1stOncology™ Service Guarantee
Unlimited support for your research from our experienced analysts dedicated to the field of cancer drug development.